TherapeuticsMD (TXMD) Other Gross PP&E Adjustments (2016 - 2025)
TherapeuticsMD's Other Gross PP&E Adjustments history spans 15 years, with the latest figure at -$5.3 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 13.26% year-over-year to -$5.3 million; the TTM value through Dec 2025 reached -$5.3 million, up 13.26%, while the annual FY2025 figure was -$5.3 million, 13.26% up from the prior year.
- Other Gross PP&E Adjustments reached -$5.3 million in Q4 2025 per TXMD's latest filing, up from -$5.6 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$4.2 million in Q3 2022 to a low of -$10.6 million in Q2 2021.
- Average Other Gross PP&E Adjustments over 5 years is -$6.0 million, with a median of -$5.8 million recorded in 2025.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 58.64% in 2022, then crashed 37.82% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$8.0 million in 2021, then skyrocketed by 36.87% to -$5.1 million in 2022, then crashed by 33.89% to -$6.8 million in 2023, then rose by 9.88% to -$6.1 million in 2024, then increased by 13.26% to -$5.3 million in 2025.
- Per Business Quant, the three most recent readings for TXMD's Other Gross PP&E Adjustments are -$5.3 million (Q4 2025), -$5.6 million (Q3 2025), and -$6.0 million (Q2 2025).